283. 後天性赤芽球癆 Acquired pure red cell aplasia Clinical trials / Disease details

臨床試験数 : 19 / 薬物数 : 36 - (DrugBank : 23) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 102

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05559827 (ClinicalTrials.gov)	September 2022	14/9/2022	Efficacy of the antiCD38 Monoclonal Antibody Isatuximabin the Treatment of PCRA by Major ABO Mismatc ...	Randomized Prospective Trial Evaluating the Efficacy of the antiCD38 Monoclonal Antibody Isatuximabi ...	Immunological Pure Red Cell Aplasia	Drug: Isatuximab	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	15 Years	N/A	All	90	Phase 2	NULL

First Previous1Next Last